Cutaquig 165 mg/mL

Cutaquig 165 mg/mL is a subcutaneous immunoglobulin G solution used to treat immune deficiencies. This product, manufactured by Pfizer Laboratories, helps support the immune system in individuals with primary immunodeficiency.

Cutaquig 165 mg/mL is primarily used for the treatment of primary immunodeficiency disorders. This medication helps to replace the antibodies that are missing or not functioning properly in the body. It is often prescribed for individuals who have difficulty fighting infections due to low levels of immunoglobulin G. The solution is administered subcutaneously, providing a convenient and effective method of delivery.

Common effects of Cutaquig 165 mg/mL may include redness, swelling, or itching at the injection site. Some individuals may also experience mild headaches or fatigue. These effects are generally temporary and should subside as the body adjusts to the medication. If any severe or persistent effects occur, it is important to consult a healthcare provider.

Cutaquig 165 mg/mL should be handled with care to ensure proper administration. The solution should be stored at the appropriate temperature and protected from light. It is important to follow the instructions provided by a healthcare provider for the correct use and disposal of the medication. Always check the expiration date before use.

Cutaquig 165 mg/mL may interact with certain medications or substances. It is important to inform a healthcare provider about all current medications, including over-the-counter drugs and supplements, before starting treatment. Alcohol and other substances may also affect the effectiveness of the medication. Always consult a healthcare provider for personalized advice.